Aberrant activation of the MAPK pathway is present in over 80% of primary melanomas (Platz et al, 2008), and mutations in proteins along the RAS-RAF-MEK-ERK pathway are thought to be mutually exclusive. Here, RAF1 is linked to melanoma.